Template:Major Drug Groups: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
<translate> | <translate> | ||
<!--T:1--> | |||
{{Navbox | {{Navbox | ||
|name =Major Drug Groups | |name =Major Drug Groups | ||
| Line 7: | Line 7: | ||
|state={{{state<includeonly>|autocollapse</includeonly>}}} | |state={{{state<includeonly>|autocollapse</includeonly>}}} | ||
<!--T:2--> | |||
|group1=[[Human gastrointestinal tract|gastrointestinal tract]]<br />/ [[metabolism]] ([[ATC code A|A]]) | |group1=[[Human gastrointestinal tract|gastrointestinal tract]]<br />/ [[metabolism]] ([[ATC code A|A]]) | ||
|list1= | |list1= | ||
| Line 21: | Line 22: | ||
*[[Dietary mineral]]s | *[[Dietary mineral]]s | ||
<!--T:3--> | |||
|group2=[[blood]] and blood<br />forming organs ([[ATC code B|B]]) | |group2=[[blood]] and blood<br />forming organs ([[ATC code B|B]]) | ||
|list2= | |list2= | ||
| Line 32: | Line 34: | ||
**[[Antifibrinolytic]]s | **[[Antifibrinolytic]]s | ||
<!--T:4--> | |||
|group3=[[Circulatory system|cardiovascular<br />system]] ([[ATC code C|C]]) | |group3=[[Circulatory system|cardiovascular<br />system]] ([[ATC code C|C]]) | ||
|list3= | |list3= | ||
| Line 52: | Line 55: | ||
**[[Bile acid sequestrant]]s | **[[Bile acid sequestrant]]s | ||
<!--T:5--> | |||
|group4=[[Human skin|skin]] ([[ATC code D|D]]) | |group4=[[Human skin|skin]] ([[ATC code D|D]]) | ||
|list4= | |list4= | ||
| Line 60: | Line 64: | ||
*[[ATC code D09|Medicated dressings]] | *[[ATC code D09|Medicated dressings]] | ||
<!--T:6--> | |||
|group5=[[Genitourinary system|genitourinary<br />system]] ([[ATC code G|G]]) | |group5=[[Genitourinary system|genitourinary<br />system]] ([[ATC code G|G]]) | ||
|list5= | |list5= | ||
| Line 67: | Line 72: | ||
*[[Sex steroid|Sex hormones]] | *[[Sex steroid|Sex hormones]] | ||
<!--T:7--> | |||
|group6=[[Endocrine system|endocrine<br />system]] ([[ATC code H|H]]) | |group6=[[Endocrine system|endocrine<br />system]] ([[ATC code H|H]]) | ||
|list6= | |list6= | ||
| Line 76: | Line 82: | ||
*[[Thyroid hormone]]s / [[Antithyroid agent]]s | *[[Thyroid hormone]]s / [[Antithyroid agent]]s | ||
<!--T:8--> | |||
|group7=[[infection]]s and<br />[[Wikt:infestation|infestations]] ([[ATC code J|J]], [[ATC code P|P]], [[ATCvet code QI|QI]]) | |group7=[[infection]]s and<br />[[Wikt:infestation|infestations]] ([[ATC code J|J]], [[ATC code P|P]], [[ATCvet code QI|QI]]) | ||
|list7= | |list7= | ||
| Line 88: | Line 95: | ||
*[[Vaccine]]s | *[[Vaccine]]s | ||
<!--T:9--> | |||
|group8=[[malignant]] disease<br />([[ATC code L|L01–L02]]) | |group8=[[malignant]] disease<br />([[ATC code L|L01–L02]]) | ||
|list8= | |list8= | ||
| Line 97: | Line 105: | ||
**[[Topoisomerase inhibitor]]s | **[[Topoisomerase inhibitor]]s | ||
<!--T:10--> | |||
|group9=[[Immune system|immune]] disease<br />([[ATC code L|L03–L04]]) | |group9=[[Immune system|immune]] disease<br />([[ATC code L|L03–L04]]) | ||
|list9= | |list9= | ||
| Line 103: | Line 112: | ||
**[[Immunosuppressive drug|Immunosuppressants]] | **[[Immunosuppressive drug|Immunosuppressants]] | ||
<!--T:11--> | |||
|group10=[[muscle]]s, [[bone]]s,<br />and [[joint]]s ([[ATC code M|M]]) | |group10=[[muscle]]s, [[bone]]s,<br />and [[joint]]s ([[ATC code M|M]]) | ||
|list10= | |list10= | ||
| Line 113: | Line 123: | ||
*[[Bisphosphonate]]s | *[[Bisphosphonate]]s | ||
<!--T:12--> | |||
|group11=[[Human brain|brain]] and<br />[[nervous system]] ([[ATC code N|N]]) | |group11=[[Human brain|brain]] and<br />[[nervous system]] ([[ATC code N|N]]) | ||
|list11= | |list11= | ||
| Line 148: | Line 159: | ||
*[[Wakefulness-promoting agent]]s | *[[Wakefulness-promoting agent]]s | ||
<!--T:13--> | |||
|group12=[[Respiratory system|respiratory<br />system]] ([[ATC code R|R]]) | |group12=[[Respiratory system|respiratory<br />system]] ([[ATC code R|R]]) | ||
|list12= | |list12= | ||
| Line 155: | Line 167: | ||
*[[H1 antagonist|H<sub>1</sub> antagonists]] | *[[H1 antagonist|H<sub>1</sub> antagonists]] | ||
<!--T:14--> | |||
|group13=[[Sense|sensory organs]] ([[ATC code S|S]]) | |group13=[[Sense|sensory organs]] ([[ATC code S|S]]) | ||
|list13= | |list13= | ||
| Line 160: | Line 173: | ||
*[[Otology|Otologicals]] | *[[Otology|Otologicals]] | ||
<!--T:15--> | |||
|group14=other [[Anatomical Therapeutic Chemical Classification System|ATC]] ([[ATC code V|V]]) | |group14=other [[Anatomical Therapeutic Chemical Classification System|ATC]] ([[ATC code V|V]]) | ||
|list14= | |list14= | ||
| Line 168: | Line 182: | ||
*[[Senotherapeutics]] | *[[Senotherapeutics]] | ||
<!--T:16--> | |||
|below= | |below= | ||
*{{Icon|Category}} [[:Category:Drugs|Drugs]] | *{{Icon|Category}} [[:Category:Drugs|Drugs]] | ||
Latest revision as of 07:33, 6 July 2023
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System (Japanese version) | |
|---|---|
| gastrointestinal tract / metabolism (A) | |
| blood and blood forming organs (B) | |
| cardiovascular system (C) | |
| skin (D) | |
| genitourinary system (G) | |
| endocrine system (H) | |
| infections and infestations (J, P, QI) | |
| malignant disease (L01–L02) | |
| immune disease (L03–L04) | |
| muscles, bones, and joints (M) | |
| brain and nervous system (N) |
|
| respiratory system (R) | |
| sensory organs (S) | |
| other ATC (V) | |
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Major Drug Groups|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Major Drug Groups|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Major Drug Groups|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.